D&D Pharmatech (347850.KQ) — Stock Score Summary

D&D Pharmatech (347850.KQ) has a MoatMap StockRank of 23/100 based on Quality (29/100), Value (34/100), and Momentum (46/100) factor scores. The current signal is SELL.

D&D Pharmatech Inc. engages in the research and development and manufacturing of pharmaceuticals in South Korea.

Key Financial Metrics

Price$60.89
Market Cap$2.6B
Price/Book50.66
Return on Equity-35.0%
Return on Invested Capital-26.5%
Debt/Equity8.11
Gross Margin99.2%
Operating Margin-8636.7%
Revenue Growth-90.9%
Free Cash Flow$-14K

D&D Pharmatech operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is D&D Pharmatech’s (347850.KQ) StockRank?
MoatMap’s StockRank for D&D Pharmatech (347850.KQ) is 23/100, with a Sell signal. It is a composite of Quality (29), Value (34), and Momentum (46) factor ranks across MoatMap’s 19,000+ stock universe.
Does D&D Pharmatech have an economic moat?
D&D Pharmatech (347850.KQ) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is D&D Pharmatech a buy, hold, or sell?
MoatMap’s current signal for D&D Pharmatech (347850.KQ) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is D&D Pharmatech in?
D&D Pharmatech (347850.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks347850.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock